<?xml version="1.0" encoding="UTF-8" ?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Cayman Journal - Enveric Biosciences Inc (ENVB)</title>
    <description>Latest news, press releases, and SEC filings for Enveric Biosciences Inc (ENVB)</description>
    <link>https://caymanjournal.com/stock/ENVB</link>
    <language>en-us</language>
    
    <copyright>Copyright 2026, Cayman Journal</copyright>
    <managingEditor>editorial@caymanjournal.com (Editorial Team)</managingEditor>
    <webMaster>webmaster@caymanjournal.com (Web Master)</webMaster>
    <lastBuildDate>Mon, 27 Apr 2026 20:26:41 GMT</lastBuildDate>
    <ttl>60</ttl>
    <atom:link href="https://caymanjournal.com/stock/ENVB/feed.xml" rel="self" type="application/rss+xml" />
    <image>
      <url>https://caymanjournal.com/logo.png</url>
      <title>Cayman Journal</title>
      <link>https://caymanjournal.com</link>
      <width>144</width>
      <height>144</height>
    </image>

    <item>
      <title>8-K — Enveric Biosciences, Inc.</title>
      <description># 📜 What This Document Is 📰

This document is a highly technical piece of legal paperwork, specifically an exhibit to an 8-K (Current Report) filing. Essentially, it is a **Securities Purchase Agreement**. This agreement governs a large &quot;private placement,&quot; which means the company (Enveric Bioscie</description>
      <link>https://caymanjournal.com/stock/ENVB/sec-filing/0001493152-26-017960</link>
      <guid isPermaLink="true">https://caymanjournal.com/stock/ENVB/sec-filing/0001493152-26-017960</guid>
      <pubDate>Mon, 20 Apr 2026 00:00:00 GMT</pubDate>
      
      <category>SEC Filing</category>
      
    </item><item>
      <title>8-K — Enveric Biosciences, Inc.</title>
      <description># 🧾 What This Document Is
This is a current report on Form 8-K, which companies file with the SEC to announce major events. Attached is a press release (Exhibit 99.1) detailing Enveric&apos;s financial results for 2025 and a major corporate update. Think of it as the company&apos;s &quot;year-in-review&quot; and &quot;here</description>
      <link>https://caymanjournal.com/stock/ENVB/sec-filing/0001493152-26-013290</link>
      <guid isPermaLink="true">https://caymanjournal.com/stock/ENVB/sec-filing/0001493152-26-013290</guid>
      <pubDate>Fri, 27 Mar 2026 00:00:00 GMT</pubDate>
      
      <category>SEC Filing</category>
      
    </item>
  </channel>
</rss>